Dimethyl Fumarate, an Approved Multiple Sclerosis Treatment, Reduces Brain Oxidative Stress in SIV-Infected Rhesus Macaques: Potential Therapeutic Repurposing for HIV Neuroprotection

Dimethyl fumarate (DMF), an antioxidant/anti-inflammatory drug approved for the treatment of multiple sclerosis, induces antioxidant enzymes, in part through transcriptional upregulation. We hypothesized that DMF administration to simian immunodeficiency virus (SIV)-infected rhesus macaques would in...

Disgrifiad llawn

Manylion Llyfryddiaeth

Prif Awduron:	Yoelvis Garcia-Mesa, He N. Xu, Patricia Vance, Analise L. Gruenewald, Rolando Garza, Cecily Midkiff, Xavier Alvarez-Hernandez, David J. Irwin, Alexander J. Gill, Dennis L. Kolson
Fformat:	Artigo
Iaith:	Inglês
Cyhoeddwyd:	MDPI AG 2021-03-01
Cyfres:	Antioxidants
Pynciau:	SIV HIV-associated neurocognitive disorders fumaric acid esters dimethyl fumarate DMF oxidative stress
Mynediad Ar-lein:	https://www.mdpi.com/2076-3921/10/3/416
Tagiau:	Ychwanegu Tag Dim Tagiau, Byddwch y cyntaf i dagio'r cofnod hwn!